Tag: Health Care

Displaying 1 - 20 of 1006 results.

Pages

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Bausch + Lomb parent company Valeant Pharmaceuticals International, Inc. illegally acquired Paragon Holdings I, Inc.
OFTACOOP, a Puerto Rico ophthalmologist cooperative, has agreed to settle Federal Trade Commission charges that its actions harmed competition. The complaint charges that  OFTACOOP – also known as Cooperativa de Médico Oftalmólogos de Puerto Rico –  unlawfully orchestrated an agreement among...
Mallinckrodt ARD Inc., formerly known as Questcor Pharmaceuticals, Inc., and its parent company, Mallinckrodt plc, have agreed to pay $100 million to settle Federal Trade Commission charges that they violated the antitrust laws when Questcor acquired the rights to a drug that threatened its...
Mallinckrodt ARD Inc., formerly known as Questcor Pharmaceuticals, Inc., and its parent company, Mallinckrodt plc, agreed to pay $100 million to settle charges that they violated the antitrust laws when Questcor acquired the rights to a drug that threatened its monopoly in the U.S....
The Federal Trade Commission announced today that it is hosting a workshop in Washington, DC on April 18, 2017, to examine competition, innovation, and consumer protection issues raised by hearing health and technology, particularly hearing aids and devices with similar functions and features.
Federal Trade Commission staff has submitted a comment to the Iowa Board of Physician Assistants supporting a regulatory proposal to define physician supervision of a physician assistant (PA), in response to a Board request for public comments.
FTC staff submitted a comment to the Delaware Board of Speech/Language Pathologists, Audiologists and Hearing Aid Dispensers on its proposed regulation that would allow telepractice in those fields but require an initial in-person evaluation. Staff stated that allowing telepractice...
Federal Trade Commission staff submitted a comment to the Delaware Board of Speech/Language Pathologists, Audiologists and Hearing Aid Dispensers on its proposed regulation that would allow telepractice in those fields but require an initial in-person evaluation.
Discussion of the Potential Issuance of A Certificate of Public Advantage For the Proposed Merger Between Mountain States Health Alliance and Wellmont Health System
FTC staff submitted a comment to the Tennessee Department of Health that opposes issuing a certificate of public advantage (COPA) to Mountain States Health Alliance and Wellmont Health System. If approved, the COPA could allow the merger of Mountain States and Wellmont, the two...
More than 40 million U.S. consumers benefit from contact lens competition. Demand for contact lenses has been growing over the past decade, and there are more places for consumers to shop for contact lenses and refill their prescriptions – in-person from eye-care providers, optical...
The Federal Trade Commission is seeking public comment on proposed amendments to the Contact Lens Rule, as well as several other issues related to the Rule.
The Federal Trade Commission filed an amicus brief with the U.S. Court of Appeals for the First Circuit urging the court to reverse the district court’s dismissal of the complaint in Amphastar Pharmaceuticals, Inc. v. Momenta Pharmaceuticals, Inc.
Brief of the Federal Trade Commission as amicus curiae, taking no position on the merits of the case, but explaining that the district court erroneously dismissed the complaint on Noerr-Pennington antitrust exemption grounds.

Pages